Revelation Biosciences, Inc. (REVBW) stock
REVBWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as REVB
$0.01+0.00 (0.00%)
Close on Oct 30, 2026Market cap $16.05MP/E –Yield –
Revelation Biosciences cash
Cash and short-term investments held at the end of each period.
Revelation Biosciences's cash was $11.48M at Jun 30, 2026. For fiscal 2025 it was $10.70M, up 64.6% from the year before. The highest annual figure on record is $11.99M in fiscal 2023.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.70M | +64.6% |
| FY2024 | Dec 31, 2024 | $6.50M | -45.8% |
| FY2023 | Dec 31, 2023 | $11.99M | +128.3% |
| FY2022 | Dec 31, 2022 | $5.25M | +312.1% |
| FY2021 | Dec 31, 2021 | $1.27M | -74.6% |
| FY2020 | Dec 31, 2020 | $5.02M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $11.48M | +121.9% |
| Q1 FY2026 | Mar 31, 2026 | $14.11M | +281.0% |
| Q4 FY2025 | Dec 31, 2025 | $10.70M | +64.6% |
| Q3 FY2025 | Sep 30, 2025 | $12.71M | +94.3% |
| Q2 FY2025 | Jun 30, 2025 | $5.17M | -57.1% |
| Q1 FY2025 | Mar 31, 2025 | $3.70M | -74.5% |
| Q4 FY2024 | Dec 31, 2024 | $6.50M | -45.8% |
| Q3 FY2024 | Sep 30, 2024 | $6.54M | -53.3% |
| Q2 FY2024 | Jun 30, 2024 | $12.07M | -23.2% |
| Q1 FY2024 | Mar 31, 2024 | $14.55M | -17.8% |
| Q4 FY2023 | Dec 31, 2023 | $11.99M | +128.3% |
| Q3 FY2023 | Sep 30, 2023 | $13.99M | +125.9% |
| Q2 FY2023 | Jun 30, 2023 | $15.71M | +352.0% |
| Q1 FY2023 | Mar 31, 2023 | $17.70M | +146.3% |
| Q4 FY2022 | Dec 31, 2022 | $5.25M | +312.1% |
| Q3 FY2022 | Sep 30, 2022 | $6.20M | +49.0% |
| Q2 FY2022 | Jun 30, 2022 | $3.48M | -47.9% |
| Q1 FY2022 | Mar 31, 2022 | $7.19M | -30.9% |
| Q4 FY2021 | Dec 31, 2021 | $1.27M | -74.6% |
| Q3 FY2021 | Sep 30, 2021 | $4.16M | +25.2% |
| Q2 FY2021 | Jun 30, 2021 | $6.67M | – |
| Q1 FY2021 | Mar 31, 2021 | $10.41M | – |
| Q4 FY2020 | Dec 31, 2020 | $5.02M | – |
| Q3 FY2020 | Sep 30, 2020 | $3.32M | – |